Polymorphic miRNA-mediated gene contribution to inhibitor development in haemophilia A

Haemophilia

Volumn 18, Issue 6, 2012, Pages 1003-1007

  Bafunno, V ^a   Santacroce, R ^a   Chetta, M ^a   Peyvandi, F ^b   Sessa, F ^a   Chinni, E ^c   Longo, V ^a   Margaglione, M ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Atherosclerosis and Thrombosis Unit Research Department   (Italy)

Author keywords

Autoimmune disease; Haemophilia A; Inhibitors; MiRNA; Polymorphisms; Susceptibility

Indexed keywords

BLOOD CLOTTING FACTOR 8; INTERLEUKIN 10; MICRORNA; MICRORNA 1184; MICRORNA 142; MICRORNA 146A; MICRORNA 150; MICRORNA 155; MICRORNA 181A; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DNA SEQUENCE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; GENE TARGETING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEMATOPOIETIC CELL; HEMOPHILIA A; HUMAN; INTRON; ITALY; MAJOR CLINICAL STUDY; POLYMORPHIC LOCUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

3' UNTRANSLATED REGIONS; ALLELES; DATABASES, GENETIC; DISEASE SUSCEPTIBILITY; FACTOR VIII; HEMOPHILIA A; HUMANS; INTERLEUKIN-10; INTRONS; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84868211753     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2012.02882.x     Document Type: Article

References (30)

1. White GC II, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 2001; 85: 560-75.
2. Berntorp E, Shapiro AD. Modern haemophilia care. Lancet 2012; 379: 1447-56.
3. Wight J, Paisley S. The epidemiology of inhibitors in haemophilia A: a systematic review. Haemophilia 2003; 9: 418-35.
4. Oldemburg J, Schröder J, Brackmann HH et al. Environmental and genetic factors influencing inhibitor development. Seminar. Hematology 2004; 41: 82-8.
5. Gouw SC, van den Berg HM. The multifactorial etiology of inhibitor development in haemophilia: genetics and environment. Semin Thromb Hemost 2009; 35: 723-34.
6. Pavlova A, Delev D, Lacroix-Desmazes S et al. Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe haemophilia A. J Thromb Haemost 2009; 7: 2006-15.
7. Astermark J, Oldenburg J, Pavlova A et al. Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with haemophilia A. Blood 2006; 107: 3167-72.
8. Astermark J, Oldenburg J, Carlson J et al. Polymorphisms in the TNFα gene and the risk of inhibitor development in patients with haemophilia A. Blood 2006; 108: 3739-45.
9. Bafunno V, Santacroce R, Chetta M et al. Polymorphisms in genes involved in autoimmune disease and the risk of FVIII inhibitor development in Italian patients with haemophilia A. Haemophilia 2010; 16: 469-73.
10. Astermark J, Altisent C, Batorova A et al. European Haemophilia Therapy Standardisation Board. Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report. Haemophilia 2010; 16: 747-66.
11. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-5.
12. Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs. Science 2005; 309: 1519-24.
13. Lodish HF, Zhou B, Liu G et al. Micromanagement of the immune system by microRNAs. Nat Rev Immunol 2008; 8: 120-30.
14. Taganov KD, Boldin MP, Baltimore D. MicroRNAs and immunity: tiny players in a big field. Immunity 2007; 26: 133-7.
15. Dai R, Ahmed SA. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res 2011; 157: 163-79.
16. Sethupathy P, Collins FS. MicroRNA target site polymorphisms and human disease. Trends Genet 2008; 24: 489-97.
17. Zhang J, Yang B, Ying B et al. Association of pre-microRNAs genetic variants with susceptibility in systemic lupus erythematosus. Mol Biol Rep 2011; 38: 1463-8.
18. Yang B, Zhang JL, Shi YY et al. Association study of single nucleotide polymorphisms in pre-miRNA and rheumatoid arthritis in a Han Chinese population. Mol Biol Rep 2011; 38: 4913-9.
19. Margaglione M, Castaman G, Morfini M et al. AICE-Genetics Study Group. The Italian AICE-Genetics haemophilia A database: results and correlation with clinical phenotype. Haematologica 2008; 93: 722-8.
20. Miller SA, Dykes DD, Polesky HE. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988; 16: 12-5.
21. Bao L, Zhou M, Wu L et al. PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits. Nucleic Acids Res 2007; 35: D51-4.
22. Hiard S, Charlier C, Coppieters W, Georges M, Baurain D. Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates. Nucleic Acids Res 2010; 38: D640-51.
23. Matsui H, Hegadorn C, Ozelo M et al. microRNA-regulated and GP64-pseudotyped lentiviral vector mediates stable expression of FVIII in a murine model of Haemophilia A. Mol Ther 2011; 19: 723-30.
24. Brown BD, Cantore A, Annoni A et al. A microRNA-regulated lentiviral vector mediates stable correction of haemophilia B mice. Blood 2007; 110: 4144-52.
25. Bandiera S, Hatem E, Lyonnet S, Henrion-Caude A. microRNAs in diseases: from candidate to modifier genes. Clin Genet 2010; 77: 306-13.
26. Li QJ, Chau J, Ebert PJ et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007; 129: 147-61.
27. Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci USA 2007; 104: 7080-5.
28. Thai TH, Calado DP, Casola S et al. Regulation of the germinal center response by microRNA-155. Science 2007; 316: 604-8.
29. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappa-B-dependent induction of microRNA miR-146, an inhibitor targeted to signalling proteins of innate immune response. Proc Natl Acad Sci USA 2006; 103: 12481-6.
30. Subramanian S, Lui WO, Lee CH et al. MicroRNA expression signature of human sarcomas. Oncogene 2008; 27: 2015-26.